A method for assessing a patient's risk of developing or having insulin resistance syndrome, insulin resistance disorders, and/or Type-2 diabetes, based on NMR measured lipoprotein-based information, comprising the steps of:
- obtaining at least one proton NMR spectroscopic signal of a patient's blood plasma or serum sample to perform a NMR spectral analysis thereof;
- deriving a NMR-based lipoprotein measurement value for a plurality of lipoprotein subclass constituents based on said obtaining step;
- comparing the NMR-based measured lipoprotein subclass constituent values to predetermined test criteria, wherein the predetermined test criteria define unfavorable or positive risk factors for each of the lipoprotein subclass constituents of interest which are associated with insulin resistance syndrome, insulin resistance disorders and/or Type 2 diabetes;
- and
- assessing a patient's risk of developing or having insulin resistance syndrome, insulin resistance disorders, and/or Type-2 diabetes based on the number of and/or degree of risk associated with the plurality of individual lipoprotein subclass constituents that are identified as having an unfavorable or positive risk factor in said comparing step.